NetworkNewsBreaks – PreveCeutical Medical Inc. (
Post# of 77
(Total Views: 215)
Posted On: 05/17/2018 6:02:29 PM
NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Shareholders Approve Proposed Forward Stock Split
Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that during its annual general and special meeting of shareholders on May 14, 2018, the proposed forward stock split of PreveCeutical’s issued and outstanding common shares on the basis of five new common shares for each one existing common share was approved by the company’s shareholders. Subject to approval by the Canadian Securities Exchange, the record date for the stock split will be May 24, 2018. On or about May 30, 2018, the company’s transfer agent will issue the additional number of common shares to shareholders of record as a result of the stock split. “We believe the stock split demonstrates the company’s continued commitment to broaden its shareholder base and we anticipate that the stock split will make PreveCeutical’s securities more accessible to investors and enhance liquidity for shareholders,” PreveCeutical CEO, president and chairman Stephen Van Deventer stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that during its annual general and special meeting of shareholders on May 14, 2018, the proposed forward stock split of PreveCeutical’s issued and outstanding common shares on the basis of five new common shares for each one existing common share was approved by the company’s shareholders. Subject to approval by the Canadian Securities Exchange, the record date for the stock split will be May 24, 2018. On or about May 30, 2018, the company’s transfer agent will issue the additional number of common shares to shareholders of record as a result of the stock split. “We believe the stock split demonstrates the company’s continued commitment to broaden its shareholder base and we anticipate that the stock split will make PreveCeutical’s securities more accessible to investors and enhance liquidity for shareholders,” PreveCeutical CEO, president and chairman Stephen Van Deventer stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)PreveCeutical Medical Inc. (PRVCF) Stock Research Links
Scroll down for more posts ▼